To evaluate the improvement in exercise capacity, renal function, and cardiac parameters of participants with chronic kidney disease (CKD), heart failure, and iron deficiency after administering an interventional agent like intravenous iron.
Phase 2
- Conditions
- Health Condition 1: N18- Chronic kidney disease (CKD)
- Registration Number
- CTRI/2024/06/068710
- Lead Sponsor
- Shrinath Mashale
- Brief Summary
Not available
- Detailed Description
Not available
Recruitment & Eligibility
- Status
- ot Yet Recruiting
- Sex
- Not specified
- Target Recruitment
- 0
Inclusion Criteria
Age more than 18 years
left ventricular ejection fraction less than 50%
NYHA class 2-4
CKD with estimated glomerular filtration rate less than 60 ml/min/1.73m2
Iron deficiency serum iron less than 800ug/ml and transferrin saturation less than 30%
No previous exposure to intravenous iron therapy within last 3 months
Exclusion Criteria
Haematological criteria serum ferritin more than 800ug/ml Transferrin saturation more than 30 %
CKD patients on maintenance hemodialysis
Already received IV iron
contraindications to iron therapy
Study & Design
- Study Type
- Interventional
- Study Design
- Not specified
- Primary Outcome Measures
Name Time Method
- Secondary Outcome Measures
Name Time Method